Mammography

Radiologists can maximize their diagnoses of lung abnormalities using computer-aided detection systems if they develop a better understanding of the strengths and shortcomings of every factor involved in the process, according to studies presented at the 2006 RSNA meeting.

News that two views are better than one with the emerging and promising technology of breast tomosynthesis raises questions about the technique's practicality and cost-effectiveness as a screening tool.

As if haunted by some kind of Ghost of Healthcare Future, the latest crop of breast imaging papers reported at the RSNA meeting conveyed an ominous undercurrent of uncertainty.

Epix scores with GSK allianceSiemens ties into Fuji CR mammographyBRIT unveils multimodality mammography workstation

Toshiba spotlights CT workflowChina pays for optical mammographyKodak, NDMA ally in Europe

Viatronix merges CAD, virtual colonographyReview of DMIST exposes downside of digital mammographyAurora Imaging heads for China AllRad strikes deal with national PPO

Full-field digital mammography yields higher cancer detection rates than conventional mammography but also boosts recall rates, according to large European studies involving thousands of women. Study findings were presented at the RSNA meeting last week.

The validity of population-based breast screening has once again been called into question by the world's media. The negative headlines have, ironically, been triggered by a report that finds mammography screening saves lives. But it is the concurrent likelihood of overdiagnosis that has captured journalists' attention.

Molecular imaging is maturing as a scientific force in preclinical research and as a mechanism to guide imaging discoveries toward clinical practice.

Full-field digital mammography yields higher cancer detection and recall rates than conventional mammography, based on large European studies involving thousands of women. Study findings were presented at the RSNA meeting Tuesday.

News that two views are better than one with the emerging and promising technology of breast tomosynthesis raises questions about the technique’s practicality and cost-effectiveness as a screening tool.

Computed radiography arrived at the RSNA meeting Sunday ready for sale into the U.S. market as a mammography application. At the head of the pack was Fujifilm Medical Systems USA, the only vendor with FDA approval to sell CR for mammography. It received the agency green light in July.

New analyses of data from the Digital Mammographic Imaging Screening Trial show that digital mammography is superior only for pre- and perimenopausal women with dense breasts. Screen-film mammography may actually have an edge in older women with fatty breasts, according to a study presented at the RSNA meeting on Sunday.

Computed radiography arrived at the RSNA meeting Sunday ready for sale into the U.S. market as a mammography application. At the head of the pack was Fujifilm Medical Systems USA, the only vendor with FDA approval to sell CR for mammography. It received the agency green light in July.

New analyses of data from the Digital Mammographic Imaging Screening Trial show that digital mammography is superior only for pre- and perimenopausal women with dense breasts. Screen-film mammography may actually have an edge in older women with fatty breasts, according to a study presented at the RSNA meeting on Sunday.

There are two ways into the U.S. market for computed radiography for mammography. One path, successfully traversed by FujiFilm Medical Systems USA and now being trod by Kodak, is the FDA's premarket approval (PMA) process. But Konica Minolta is taking the road less traveled.

iCAD readies RSNA exhibitsUltraRad offers free offsite archivingSiemens snags $40M dealGE expands alliance with Intermountain

Kodak will showcase its computed radiography platform for mammography at the RSNA meeting, but it will have to do so as a work-in-progress, at least for customers in the U.S.

Kodak submits CR mammography data to FDAContextVision installs low-dose CT featureSectra launches next-generation management toolFonar revenues fallInSite annual revenues grow 56%Digital x-ray digs in

The imaging industry tallied another 34 FDA clearances in September, pushing the running count for the year to 261. Image management led all categories with 14 devices, followed by x-ray with 10, radiotherapy with four, ultrasound and CT each with two, and nuclear medicine with one. A surgical microscope accessory that is used to view intraoperative cerebral blood flow fits none of the traditional categories.

Cedara readies oncology toolsNEMA, ACR plan ethics program at RSNA meetingEmageon prepares RSNA launchesU-Systems taps service providerVolcano turns profitAmicas revenues slipKodak attracts Magnet deal

Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality.

I routinely read and enjoy the column by Dr. Bradley Tipler. But I was shocked and disappointed by the article in the June 2006 edition, ("Command of a tight ship stays out of reach," page 64). I work on the other side of the table.

For years, the world of breast imaging was quite simple. Screen-film mammography and ultrasound did not leap ahead, but they did a satisfactory job for most women. In the past few years, the armamentarium has exploded, with the introduction of modalities from MRI to vacuum biopsy. The management of breast disease has changed significantly.

The validity of population-based breast screening has once again been called into question by the world’s media. The negative headlines have, ironically, been triggered by a report that finds mammography screening saves lives. But it is the concurrent likelihood of overdiagnosis that has captured journalists’ attention.

Philips introduces ultrasound upgradesDynamic Imaging readies digital mammography

Six years ago, Hologic looked like a company on the brink. Once the darling of the radiology industry with booming sales of bone densitometers, Hologic had sought to diversify, but its acquisitions were dragging the company down rather than lifting it up.

Buoyed by corporate acquisitions, Hologic will appear at the RSNA meeting with a 13,000-square-foot booth filled with works-in-progress for its mammography, CAD, and densitometry offerings, and enhanced by a first-time RSNA showing of an MRI system from Esaote and the Chicago debut of its newly acquired biopsy portfolio.

Sectra sets RSNA agendaMerge plans RSNA releasesHologic boosts European presenceX-ray parent moves to new digs